Magnus Financial Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,478
Closed -$1.74M 279
2023
Q1
$1.74M Buy
3,478
+12
+0.3% +$5.74K 0.26% 70
2022
Q4
$1.41M Sell
3,466
-1,006
-22% -$391K 0.23% 78
2022
Q3
$1.46M Sell
4,472
-531
-11% -$195K 0.28% 71
2022
Q2
$1.75M Sell
5,003
-8
-0.2% -$3.26K 0.32% 56
2022
Q1
$2.74M Buy
5,011
+1,549
+45% +$815K 0.46% 37
2021
Q4
$2.28M Hold
3,462
0.43% 38
2021
Q3
$2.15M Hold
3,462
0.46% 35
2021
Q2
$2.19M Hold
3,462
0.48% 34
2021
Q1
$1.69M Sell
3,462
-360
-9% -$180K 0.41% 38
2020
Q4
$1.91M Sell
3,822
-1,540
-29% -$689K 0.19% 47
2020
Q3
$2.11M Buy
5,362
+891
+20% +$329K 0.25% 35
2020
Q2
$1.48M Buy
4,471
+657
+17% +$190K 0.16% 54
2020
Q1
$924K Buy
+3,814
New +$995K 0.13% 81

Other funds holding IDXX

Magnus Financial Group's IDXX Position: Q2 2023 in Review

Magnus Financial Group sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 3,478 shares — an estimated $1.74M sold.

Magnus Financial Group first reported a position in IDXX in Q1 2020 and held it in 13 quarters. The position peaked at $2.74M in Q1 2022. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

  • Magnus Financial Group reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
  • Magnus Financial Group sold 3,478 Idexx Laboratories shares in Q2 2023, an estimated $1.74M.
  • Magnus Financial Group first reported a position in Idexx Laboratories in Q1 2020 and held it in 13 quarters.
  • Magnus Financial Group's Idexx Laboratories position peaked at $2.74M in Q1 2022.
  • 1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Magnus Financial Group's 13F filing for Q2 2023, filed 19 Jul 2023.